June 7th 1979 1st Symposium on Infectious Diseases and Immunity: Urinary Tract Infection
A. W. Asscher Progress in prevention of urinary tract infection
Michel P. Glauser The critical role of polymorphonuclear leukocytes in kidney Infection
Ruedi Lüthy Diagnosis of urinary tract infection
R. H. Rubin The utility of single dose amoxicillin therapy of acute, uncomplicated urinary tract infection in the adult female
J.Allan McCutchan Gonorrhea and non-gonococcal urethritis
Thomas A. Stamey Basic observations on pathogenesis and treatment of recurrent urinary infections in females
March 20th 1980 2nd Symposium on Infectious Diseases and Immunity: Phagocytosis and Mechanisms of Action of Antibiotics
Richard B. Roberts Phagocytes: an overview
Richard K. Root Antibiotic-leukocyte interaction in the killing of bacteria
Gerald L. Mandell Microbes versus phagocytes
Alexander Thomasz Mode of action of penicillins
Julian E. Davies How aminoglycosides kill bacteria
April 2nd 1981 3rd Symposium on Infectious Diseases and Immunity: Newly Recognized Infectious Diseases
Lucien B. Guze Mycoplasma infections
Lawrence R. Freedman Update on Legionnaire's Disease
Marian Melish Kawasaki's disease, staphylococcal toxin - related syndromes, toxic shock syndrome, scalded skin syndrome
Edwin Beachey Bacterial adherence: adhesin- receptor interaction mediating the attachment of bacteria to mucosal surfaces
Phyllis A. Oill Sexually transmitted diseases
April 1st 1982 4th Symposium on Infectious Diseases and Immunity: Microbes, Viruses and Therapeutic Agents - New Perspectives
Mark Richmond Clinically important mechanisms of microbial resistance to antibiotics
William Craig Post-antibiotic suppression of bacterial growth: implication for dosing regimens
Thomas C. Merigan Interferon as a therapeutic agent in man
Michael Gottlieb Opportunistic infections and Kaposi's sarcoma in homosexuals
April 14th 1983 5th Symposium on Infectious Diseases and Immunity: Diarrhea and Viruses, Immune Deficiencies and Cancer
Stanley M. Lemon Primary hepatocellular carcinoma
Joseph S. Pagano Short presentation on AIDS
Sidney M. Finegold Antimicrobial agent-associated colitis
Herbert L. DuPont Bacterial diarrhea and the traveler
Joseph S. Pagano Epstein-Barr virus and malignancy
April 5th 1984 6th Symposium on Infectious Diseases and Immunity: Infective Agents and their Effects - New Perspectives
Charles A. Dinarello Fever, interleukin I and the acute phase response
James Keating Epidemiology of Reye's syndrome
Murray B. Gardener Simian Acquired Immune Deficiency Syndrome
Robert C. Gallo The family of human retroviruses (leukemia viruses) called HTL and their role and/or association with neoplasic and immune suppressive disease
April 18th 1985 7th Symposium on Infectious Diseases and Immunity: Studies of New Disease Agents
St. E. Malawista Lyme disease
Ellen R. Wald Branhamella catarrhalis: an update
Marcus A. Horwitz Intracellular wars: invasion of legionnaires disease bacteria
John L. Gerin Hepatitis delta virus: biological and clinical significance
March 13th 1986 8th Symposium on Infectious Diseases and Immunity: Mechanisms of Defense
Mark. S. Klempner Intracellular pathogens: an alternative antimicrobial strategy
Henry Rosen Neutrophil-mediated host defence: the lessons of failure
Wilfred M. Weinstein A new cause of gastroenteritis
Stanley B. Prusiner Prions, dementia and Alzheimer's disease
April 9th 1987 9th Symposium on Infectious Diseases and Immunity: New Mechanisms of Infectious Diseases
Jeffrey Parsonnet Insights into the pathogenesis of toxic shock syndrome
Anthony Cerami Cachectin: a macrophage protein that induces a catabolic state of shock
Andrew D. Pearson Campylobacter pyloridis: possible role in gastritis, peptic ulcer and carcinoma
Lance George Campylobacter infections in humans
March 24th 1988 10th Symposium on Infectious Diseases and Immunity: Immune Defense, AIDS and Retroviruses
Gerald L. Mandell Immunomodulators and infection
Francis Waldvogel Prosthetic implants: tolerance, infection and treatment
Michel P. Glauser Polymorphonuclear neutrophils as agents of disease: an example of pyelonephritis
Robert C. Gallo AIDS viruses: where do we go from here?
Ruedi Lüthy Clinical aspects of HIV-associated diseases
Marian Melish Kawasaki disease: why was it thought to be a retrovirus infection?
April 13th 1989 11th Symposium on Infectious Diseases and Immunity: Responses to Infectious Agents
Dave W. Golde Colony-stimulating factors: biology and clinical implications
Edward L. Kaplan Group A streptococcal infections: their relationship to the epidemiology and pathogenesis of acute rheumatic fever
Gary P. Holmes Current aspects of the chronic fatigue syndrome
Jay P. Sanford Lepthangumushi disease
March 22nd 1990 12th Symposium on Infectious Diseases and Immunity: Old friends - New Enemies
Robert Austrian Preventing pneumococcal infection
S. C. Silverstein Phagocytes: how they travel and how they eat
Barry J. Marshall Helicobacter pylori: should it affect our management of acid-peptic disorders?
Leonard Seeff The non-A, non-B hepatitis viruses
April 18th 1991 13th Symposium on Infectious Diseases and Immunity: New Infections and Host Defences
Gerald L. Mandell New infections
Richard Johnson The spongioform encephalopathies
Zanvil A. Cohn Cell-mediated immunity
Alan Ezekowitz The role of gamma interferons as adjuvant immunotherapy in infectious diseases
April 9th 1992 14th Symposium on Infectious Diseases and Immunity: Immunization
Samuel L. Katz Immunizations - entering the third century
Elizabeth J. Ziegler Immunotherapy of Gram-negative bacteremia
Dennis L. Stevens Invasive group A streptococcal infections
Charles A. Dinarello Blocking interleukin - in septic shock and on virulent E. Coli
March 25th 1993 15th Symposium on Infectious Diseases and Immunity: The Future and the Past
S. Jody Heymann Unindentified pathogens and the safety of the blood supply
David A. Relman The identification of uncultured pathogens
Alan Hinman Tuberculosis in the 1990's
Daniel M. Musher Sexually transmitted diseases: focus on cystitis and syphilis
March 17th 1994 16th Symposium on Infectious Diseases and Immunity: Accelerating Challenges of Infectious Disease
Allan M. Brandt From VD to STDs: sexuality and disease in the 20th century
Robert C. Gallo New strategies to control HIV and AIDS
Gerald L. Mandell Immunomodulators and infection
Patrick M. Schlievert Role of superantigens in human disease
March 23rd 1995 17th Symposium on Infectious Diseases and Immunity: Host-Microbial Interactions
Seymour J. Klebanoff Biological role of reactive oxygen species in inflammation
Daniel L. Purich Listeria monocytogenes: intracellular mechanisms of disease
Jay C. Butler Hantavirus pulmonary syndrome
Dennis L. Stevens Flesh-eating bacteria
April 11th 1996 18th Symposium on Infectious Diseases and Immunity: Challenges in Infectious Diseases
Stephen E. Malawista Lyme disease / Ehrlichiosis
W. Michael Scheld Bacterial meningitis
Robert Shope Ebola virus infection
Jacques Corbeil Apoptosis induced by HIV
February 27th 1997 19th Symposium on Infectious Diseases and Immunity: The Continuing Struggle - Microbial Virulence versus Host Defenses
Frederick S. Southwick Cell to cell transmission of Shigella
John Mekalanos Molecular basis for emergence of bacterial pathogens
Harry L. Malech Interferon gamma in the management of infections in the impaired host
Tomas Ganz Human antibiotics
March 5th 1998 20th Symposium on Infectious Diseases and Immunity: On the Threshold of the Millennium
Charles A. Dinarello Anti-cytokine therapy for inflammatory and infectious diseases
Gerald L. Mandell New and surprising infectious diseases
Robert C. Gallo AIDS research: current status and future needs
Donald B. Louria Emerging and re-emerging infections: the critical societal determinants
March 11th 1999 21st Symposium on Infectious Diseases and Immunity: The Millenium Bugs – Infectious Diseases at the Turn of the Century
Philippe J. Sansonetti Rupture and invasion of the intestinal barrier by enteric bacterial pathogens
Malak Kotb Severe streptococcal diseases and future therapeutic strategies
Alan P. Hudson Chlamydia pneumoniae in atherosclerosis and Alzheimer disease
James J. Goedert Microbes and malignancies
March 2nd 2000 22nd Symposium on Infectious Diseases and Immunity: Man-Made (and Bird-made?) Threats and Therapeutic Agents
Donald Henderson Bioterrorism
Robert G. Webster Influenza
Stuart B. Levy Antibiotic resistance
Lowell S. Young Antibiotic targeting and the search for new antimicrobial targets
15th March 2001 23rd Symposium on Infectious Diseases and Immunity: Survival of the Shrewdest
Samuel L. Katz Vaccination in the 21st century
P. Frederick Sparling Mucosal immunity
Martin Blaser Helicobacter pylori – an agent of health as well as disease?
Didier Raoult Slow growing bacteria: detecting unknown epidemics in Europe and elsewhere
Catherine Wilfert Perinatal HIV transmission
February 28th 2002 24th Annual Symposium on Infectious Agents and Immunity
Martin Rosenberg Genomic approaches to novel antiinfective agents
Stanley B. Prusiner Prion disease
Ron Dagan Otitis media, pneumococcal disease
Jay S. Keystone Travel medicine
March 20th 2003 25th Annual Infectious Diseases Symposium
Michael Osterholm Emerging infections - the next chapter
Jay A. Levy The social and economic threat of HIV/AIDS: How science faces the challenge
Henry F. Chambers Controlling Methicillin resistance of Staphylococci
David A. Relman Genome-wide expression patterns: what the host tells us about recent microbial encounters
March 25th 2004 26th Annual Infectious Diseases Symposium
Jonathan Cohen Sepsis: new insights on pathogenesis and implications for present and future treatment strategies
Jorge Gálan Pathogen-host crosstalk
Hugo Rosen Hepatitis C
Claire-Anne Siegrist Vaccines, allergy and autoimmunity: what are the risks ?
Christian Griot The avian influenza crisis in South East Asia (late breaker lecture)
March 3rd 2005 27th Annual Infectious Diseases Symposium
Thomas F Patterson Fungi: new antifungal drugs, pathogens, diagnosis
Thierry Calandra Innate Immunity
J William Costerton Biofilms and their role in antibiotic resistance
Lionel Mandell Pneumonia
Kathrin Mühlemann Avian flu: threat for human health or hysteria ? (late breaker lecture)
March 16th 2006 28th Annual Infectious Diseases Symposium
Klaus Stöhr Influenza – Who cares ?
Roy Anderson Prediction and pre-emption of major infectious disease epidemics
Adrian V S Hill Genomics & genetic predisposition: significance for infectious diseases
Jérôme Etienne Community acquired methicillin resistant Staphylococcus aureus
Stefan Lautenschlager Sexually transmitted diseases in Switzerland (late breaker lecture)
March 15th 2007 29th Annual Infectious Diseases Symposium
Michael Malim, DPhil Antiviral innate immunity
Dale N Gerding, MD New Aspects of Clostridium difficile epidemiology and disease
Bernhard R Beck, MD Chikungunya Virus Infection (late breaker lecture)
Sarah E Randolph, PhD Tick borne/vector borne diseases and climate change
Keith P Klugman, MD Streptococcus pneumoniae – impact of conjugated vaccine and antimicrobial resistance
January 31st 2008 30th Annual Infectious Diseases Symposium
Antonello Covacci, MD CagA Helicopacter pylori promotes neoplastic growth by inactivation of a tumor-suppressor function: a route to a tumor vaccine?
John T. Schiller, PhD HPV (human papilloma virus) vaccine
Sebastien Gagneux Tuberculosis: where did it come from and where is it going?
Andrew J. MacPherson, MD The human gut flora
Herman Goosens, MD, PhD Antibiotic use and resistance in the community in Europe
Kathrin Mühlemann, MD, PhD, and Giorgio Zanetti, MD, MS Swiss data on antibiotic use and resistance
Ruedi Lüthy, MD Management of HIV Infection with limited resources - implications for developed countries
March 30th 2009 31st Annual Infectious Diseases Symposium
Jeffrey N. Weiser, MD The Pneumococcus: Why a Commensal Misbehaves
Darius Moradpour, MD Current Challenges in Viral Hepatitis
Kathrin Mühlemann, MD, PhD Update on current influenza A (H1N1) outbreak (late breaker)
Daniel N. Kastner, MD, PhD Horror Autoinflammaticus: The Expanding Spectrum of Systemic Autoinflammatory Diseases
Henry F. Chambers, MD Methicillin-resistant Staphylococcus aureus: Evolution of a Community Pathogen
April 22nd 2010 32nd Annual Infectious Diseases Symposium
Jay A. Fishman, MD What do GPs, Internists and Pediatricians need to know about infections in immunocompromsed patients?
Marcel Tanner, PhD Malaria vaccines - the pace quickens
Bernard Hirschel, MD Anti-HIV drugs for prevention of HIV
Didier Raoult, MD, PhD Giant viruses
Lindsay Nicolle, MD New Developments and changing concepts for urinary tract infections
March 24th 2011 33rd Annual Infectious Diseases Symposium
Kevin Tracey, MD Neural circuits control fundamental immune responses
Brian Gazzard, MD 15 years HIV antiretroviral therapy
Werner Zimmerli, MD New concepts in foreign body / osteomyelitis infection
Lora V. Hooper, PhD The gut microbiom and its interaction with the human host
